A Pilot Study Looking At The Use Of Alfuzosin In The Treatment Of Bladder Dysfunction In Patients With Multiple Sclerosis

Trial Profile

A Pilot Study Looking At The Use Of Alfuzosin In The Treatment Of Bladder Dysfunction In Patients With Multiple Sclerosis

Discontinued
Phase of Trial: Phase II/III

Latest Information Update: 16 May 2015

At a glance

  • Drugs Alfuzosin (Primary)
  • Indications Bladder dysfunction
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Jun 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 10 Feb 2009 Planned end date changed from Nov 2008 to Nov 2009 as reported by ClinicalTrials.gov.
    • 25 Jun 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top